SPC78

Vismodegib og sölt og lausnarsambönd þess

  • Status:
    Veitt
  • Application date:
    8.10.2013
  • Application published:
    15.11.2013
  • Grant published:
    15.11.2016
  • Max expiry date:
    16.7.2028
  • Next due date:
    30.9.2026
  • Medicine name:
    Erivedge
  • Medicine for children:
    No

Timeline

Today
8.10.2013Application
15.11.2013Publication
15.11.2016Registration
1.9.2026Expires

Marketing license

  • IS authorization number:
    EU/1/13/848/001
  • Date:
    8.8.2013
  • Foreign authorization number:
    EU/1/13/848
  • Date:
    12.7.2013

Owner

  • Name:
    Genentech, Inc.
  • Address:
    1 DNA Way, South San Francisco US
  • Name:
    Curis, Inc.
  • Address:
    4 Maguire Road, Lexington, MA US

Agent

  • Name:
    Árnason Faktor ehf.
  • Address:
    Guðríðarstíg 2-4, 113 Reykjavík

Patent

Annual fees

Number

Paid

Expires

Payer

Number: 1

Paid: 27.8.2025

Expires: 1.9.2026

Payer: Árnason Faktor ehf.

Upload documents